Literature DB >> 34422697

COVID-19 deaths and associated demographic factors in Central Java, Indonesia.

Dwi Sutiningsih1, Nur Azizah Azzahra2, Yulianto Prabowo3, Aris Sugiharto4, Mufti Agung Wibowo5, Endah Sri Lestari6, Estri Aurorina6.   

Abstract

INTRODUCTION: To date, the total number of COVID-19 deaths is still increasing, including in Central Java, with the third-highest total number of deaths in Indonesia. There are still limited studies related to the cases of COVID-19. Thus, this study's objective was to provide an overview of the characteristics of 4359 COVID-19 death cases in Central Java.
METHODS: This research used a cross-sectional descriptive design with univariate, bivariate, and multivariate analysis involving secondary data acquired from a report by the Provincial Health Office of Central Java, recorded up to 13 December 2020.
RESULTS: The results showed that the highest frequencies of death cases were contributed from ≥60 years group (n=1897 patients; 43.52%) and the male (n=2497 patients; 57.28%) group. The case fatality rate (CFR) rose with age, and the highest CFR was recorded in the elderly (17.95%), males (7.60%), in Pati District (17.45%), while entrepreneur (14.64%) was the highest reported job. Furthermore, the eldest group (≥60 years) and males were more susceptible to die, with ORs 5.49 (95%CI: 5.15-5.86) and 1.61 (95%CI: 1.51-1.71), sequentially. The majority of death cases had comorbidities (65.79%), while the most prevalent reported comorbidities were diabetes (n=1387, 31.82%) and hypertension (n=817, 18.74%). Meanwhile, patients of old age were more likely to associate comorbidity, p<0.001, OR 1.664 (95%CI: 1.425-1.944).
CONCLUSIONS: This study concludes that patients of older age and males may become more vulnerable than younger and females to experience death. Further study is required to measure the relationship between other characteristics of demographics, underlying medical conditions, and fatality. GERMS.

Entities:  

Keywords:  CFR; COVID-19; age; comorbidities; gender

Year:  2021        PMID: 34422697      PMCID: PMC8373415          DOI: 10.18683/germs.2021.1262

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  17 in total

1.  Coronavirus Disease 2019 (COVID-19) in Italy.

Authors:  Edward Livingston; Karen Bucher
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

2.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.

Authors:  Chaomin Wu; Xiaoyan Chen; Yanping Cai; Jia'an Xia; Xing Zhou; Sha Xu; Hanping Huang; Li Zhang; Xia Zhou; Chunling Du; Yuye Zhang; Juan Song; Sijiao Wang; Yencheng Chao; Zeyong Yang; Jie Xu; Xin Zhou; Dechang Chen; Weining Xiong; Lei Xu; Feng Zhou; Jinjun Jiang; Chunxue Bai; Junhua Zheng; Yuanlin Song
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

3.  Real-time characterization of risks of death associated with the Middle East respiratory syndrome (MERS) in the Republic of Korea, 2015.

Authors:  Kenji Mizumoto; Akira Endo; Gerardo Chowell; Yuichiro Miyamatsu; Masaya Saitoh; Hiroshi Nishiura
Journal:  BMC Med       Date:  2015-09-30       Impact factor: 8.775

4.  Comparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and South Korea.

Authors:  Xin Chen; Abrar Ahmad Chughtai; Amalie Dyda; Chandini Raina MacIntyre
Journal:  Emerg Microbes Infect       Date:  2017-06-07       Impact factor: 7.163

5.  Age, frailty and diabetes - triple jeopardy for vulnerability to COVID-19 infection.

Authors:  A J Sinclair; A H Abdelhafiz
Journal:  EClinicalMedicine       Date:  2020-04-23

6.  Analysis on 54 Mortality Cases of Coronavirus Disease 2019 in the Republic of Korea from January 19 to March 10, 2020.

Authors: 
Journal:  J Korean Med Sci       Date:  2020-03-30       Impact factor: 2.153

7.  Case fatality of SARS in mainland China and associated risk factors.

Authors:  Na Jia; Dan Feng; Li-Qun Fang; Jan Hendrik Richardus; Xiao-Na Han; Wu-Chun Cao; Sake J de Vlas
Journal:  Trop Med Int Health       Date:  2009-04-17       Impact factor: 2.622

8.  Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico.

Authors:  Gaspar Manuel Parra-Bracamonte; Nicolas Lopez-Villalobos; Francisco E Parra-Bracamonte
Journal:  Ann Epidemiol       Date:  2020-08-14       Impact factor: 3.797

9.  Epidemiology and transmission dynamics of COVID-19 in two Indian states.

Authors:  Ramanan Laxminarayan; Brian Wahl; Shankar Reddy Dudala; K Gopal; Chandra Mohan B; S Neelima; K S Jawahar Reddy; J Radhakrishnan; Joseph A Lewnard
Journal:  Science       Date:  2020-09-30       Impact factor: 47.728

10.  Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-03-27       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.